Reuters |
EU approves Sanofi and Regeneron's dupilumab in eczema – Reuters
Reuters The European Commission approved Regeneron Pharmaceuticals' and Sanofi's key biologic treatment dupilumab for moderate-to-severe atopic dermatitis, the … Sanofi's Dupixent gets Europe eczema nod Sanofi and Regeneron's Atopic Dermatitis Approved in the EU EU Approves Dupilumab (Dupixent) for Atopic Dermatitis |
